Jack Meehan
Stock Analyst at Barclays
(3.06)
# 1,257
Out of 5,124 analysts
137
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $275 → $290 | $250.88 | +15.59% | 17 | Oct 2, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $136.07 | -8.14% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $379.83 | -24.18% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $11.46 | +187.96% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $131.16 | +147.79% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.69 | +29.34% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $173.53 | -42.95% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $182.22 | -1.22% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $6.15 | +62.60% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $225.41 | -26.36% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $74.49 | -42.27% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $199.48 | -22.80% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $302.99 | +41.92% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $301.31 | +42.71% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $28.56 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $47.11 | +1.89% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,394.19 | -51.23% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $79.70 | -62.36% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $579.45 | -48.23% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $0.91 | +4,295.60% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $275 → $290
Current: $250.88
Upside: +15.59%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $136.07
Upside: -8.14%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $379.83
Upside: -24.18%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $11.46
Upside: +187.96%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $131.16
Upside: +147.79%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.69
Upside: +29.34%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $173.53
Upside: -42.95%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $182.22
Upside: -1.22%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $6.15
Upside: +62.60%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $225.41
Upside: -26.36%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $74.49
Upside: -42.27%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $199.48
Upside: -22.80%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $302.99
Upside: +41.92%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $301.31
Upside: +42.71%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $28.56
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $47.11
Upside: +1.89%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,394.19
Upside: -51.23%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $79.70
Upside: -62.36%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $579.45
Upside: -48.23%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $0.91
Upside: +4,295.60%